Search details
1.
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer.
J Cancer Res Clin Oncol
; 150(2): 84, 2024 Feb 08.
Article
in English
| MEDLINE | ID: mdl-38329600
2.
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.
Cancers (Basel)
; 16(8)2024 Apr 11.
Article
in English
| MEDLINE | ID: mdl-38672547
3.
Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma.
J Immunother
; 47(5): 190-194, 2024 Jun 01.
Article
in English
| MEDLINE | ID: mdl-38318726
4.
Systemic treatment of a patient with relapsed and refractory extranodal NK/T-cell lymphoma (ENKL) and meningeosis leukemica with daratumumab.
Hematol Oncol
; 36(4): 713-714, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-30074631
5.
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17.
J Clin Oncol
; 41(33): 5131-5139, 2023 Nov 20.
Article
in English
| MEDLINE | ID: mdl-37590894
6.
Incidence and outcome of patients with renal cell carcinoma treated with partial or radical nephrectomy in the Cantons St Gallen and Appenzell 2009-2018.
Swiss Med Wkly
; 152: w30175, 2022 06 06.
Article
in English
| MEDLINE | ID: mdl-35752957
7.
Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma.
ESMO Open
; 5(Suppl 3)2020 07.
Article
in English
| MEDLINE | ID: mdl-32669298
Results
1 -
7
de 7
1
Next >
>>